Trial · NCT01723904
Results by group11
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 11 of 11
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Clinical Global Impression (CGI) Item 4 (Side Effects) at the End of the Treatment Period | Rotigotine | CGI Item 4 score of 1 | 61 | participants | |
| Clinical Global Impression (CGI) Item 4 (Side Effects) at the End of the Treatment Period | Rotigotine | CGI Item 4 score of 2 | 22 | participants | |
| Clinical Global Impression (CGI) Item 4 (Side Effects) at the End of the Treatment Period | Rotigotine | CGI Item 4 score of 3 | 3 | participants | |
| Clinical Global Impression (CGI) Item 4 (Side Effects) at the End of the Treatment Period | Rotigotine | CGI Item 4 score of 4 | 3 | participants | |
| Clinical Global Impression (CGI) Item 4 (Side Effects) at the End of the Treatment Period | Rotigotine | CGI Item 4 score of 3 or 4 | 6 | participants | |
| Change From Baseline to the End of the Treatment Period in the Unified Parkinson's Disease Rating Scale (UPDRS) Part III (on State) Total Score | Rotigotine | -5.3 | Standard Deviation 8.3 | units on a scale | |
| Change From Baseline to the End of the Treatment Period in the Unified Parkinson's Disease Rating Scale (UPDRS) Part II (Average of on and Off State) Total Score | Rotigotine | -1.5 | Standard Deviation 3.8 | units on a scale | |
| Change From Baseline to the End of the Treatment Period in Absolute Time Spent Off | Rotigotine | -2.1 | Standard Deviation 2.9 | hours/day | |
| Change From Baseline to the End of the Treatment Period in Time Spent on Without Troublesome Dyskinesia | Rotigotine | 1.9 | Standard Deviation 3.1 | hours/day | |
| Change From Baseline to the End of Treatment Period in Parkinson's Disease Sleep Scale 2 (PDSS-2) Total Score | Rotigotine | -3.2 | Standard Deviation 7.5 | units on a scale | |
| Change From Baseline to the End of Treatment Period in the Pittsburgh Sleep Quality Index (PSQI) Global Score | Rotigotine | -0.7 | Standard Deviation 3.0 | units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01723904/results